Table 2.
General characteristics of study participants.
| Placebo Group (n = 20) | Omega-3 Group (n = 20) | P 1 | |
|---|---|---|---|
| Gestational age before intervention (weeks) | 25.3 ± 1.1 | 25.4 ± 1.2 | 0.89 |
| Age (y) | 30.8 ± 2.4 | 30.5 ± 3.8 | 0.80 |
| Height (cm) | 162.1 ± 5.8 | 161.6 ± 3.4 | 0.71 |
| Weight at study baseline (kg) | 70.6 ± 5.7 | 73.1 ± 6.7 | 0.22 |
| Weight at end-of-trial (kg) | 72.5 ± 5.7 | 75.1 ± 6.6 | 0.19 |
| Weight change (kg) | 1.9 ± 0.6 | 2.0 ± 0.6 | 0.51 |
| BMI at study baseline (kg/m2) | 27.0 ± 3.1 | 28.0 ± 2.6 | 0.27 |
| BMI at end-of-trial (kg/m2) | 27.7 ± 3.2 | 28.8 ± 2.6 | 0.25 |
| BMI change (kg/m2) | 0.7 ± 0.2 | 0.8 ± 0.2 | 0.54 |
| MET-h/day at study baseline | 27.6 ± 2.0 | 27.1 ± 2.0 | 0.40 |
| MET-h/day at end-of-trial | 27.3 ± 2.1 | 26.9 ± 2.2 | 0.46 |
| MET-h/day change | −0.3 ± 0.5 | −0.2 ± 0.4 | 0.73 |
Data are means ±SDs. 1 Obtained from independent t-test. METs, metabolic equivalents.